✦ LIBER ✦

Phase III Trials of Eribulin Mesylate (E7389) in Extensively Pretreated Patients With Locally Recurrent or Metastatic Breast Cancer

✍ Scribed by Chris Twelves; Javier Cortes; Linda T. Vahdat; Jantien Wanders; Corina Akerele; Peter A. Kaufman

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 2, Multicenter, Single-Arm Study o

✍ Wilks, Sharon; Puhalla, Shannon; O'Shaughnessy, Joyce; Schwartzberg, Lee; Berrak 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 169 KB

Phase 2 study of eribulin mesylate as fi

✍ McIntyre, Kristi; O’Shaughnessy, Joyce; Schwartzberg, Lee; Glück, Stefan; Berrak 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 405 KB

Patupilone in patients with pretreated m

✍ Moorcraft, S. Y.; Chau, I.; Peckitt, C.; Cunningham, D.; Rao, S.; Yim, K. L.; Wa 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 175 KB

Erratum to: Phase 2 study of eribulin me

✍ McIntyre, Kristi; O’Shaughnessy, Joyce; Schwartzberg, Lee; Glück, Stefan; Berrak 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 127 KB

A phase II study of pemetrexed disodium

✍ D.W Miles; I.E Smith; R.E Coleman; A.H Calvert; M.J Lind 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Phase II Trial of Weekly Docetaxel/Gemci

✍ Joyce A. O'Shaughnessy; Robert Pluenneke; Jack Sternberg; Pankaj Khandelwal; Des 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 482 KB